Editing CUA: Neurogenic Lower Urinary Tract Dysfunction (2019) (section)

== Surveillance studies for NLUTD patients in the community setting ==
{| class="wikitable"
|'''Risk group'''
|'''Suggested surveillance strategy'''
|-
|'''High/moderate-risk'''
|
* '''Urological evaluation (history and physical examination): yearly'''
* '''Imaging: yearly'''
* '''Renal function: yearly'''
* '''UDS'''
** '''High-risk: yearly'''
** '''Moderate-risk: every 2-5 years'''
** VideoUDS or a cystogram should be performed in patients where further knowledge of the urinary tract anatomy is needed
|-
|'''Low-risk'''
|
* '''Evaluation''' with GP, physiatrist, neurologist, or urologist (history and physical examination with attention to general neuro-urological assessment outlined previously): '''yearly'''
* '''Imaging: yearly in select cases'''
* '''Re-referral for urological evaluation as suggested by:'''
** New-onset/worsening incontinence; or
** New frequent urinary infections; or
** New-onset catheter issues (for example, penile/urethral erosions, encrustation, bypassing)
** Renal-bladder imaging changes suggestive of upper or lower urinary tract deterioration (hydronephrosis, new clinically significant PVR, or significant increase in PVR) or new stone disease
|}

* When children with SB transition to adulthood, they should be followed by an adult urologist as soon as it is practical to transition them.
* We support the use of cystoscopy for the assessment of suspected urethral or bladder pathology. '''We do not support routine surveillance cystoscopy for bladder cancer screening in NLUTD with or without augmentation cystoplasty'''